Dry AMD is often an early stage of Macular Degeneration. Of those patients diagnosed with macular degeneration, about 85 to 90 percent are diagnosed with the dry form. Dry AMD is detected as yellow spots, called drusen, which accumulate from deteriorating tissue in the macula. There can also be migration of pigment which shows as areas of increased or decreased pigmentation.
When there are areas of loss of pigmentation this is referred to as Geographic Atrophy which is an advanced form of dry macular degeneration. There are currently 2 approved medications for this condition. Both Izervay (R) and Syfovre (R) have been shown to slow down progression of this form of the disease. These treatments are available at the Fort Lauderdale Eye Institute. We also are frequently involved in clinical trials with goals of improving treatment further.
